1-3 of 3
Giulio Francia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts

Giulio Francia, Shan Man, Chyan-Jang Lee, Christina R. Lee, Ping Xu, Miriam E. Mossoba, Urban Emmenegger, Jeffrey A. Medin, Robert S. Kerbel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (20): 6358–6366.
DOI: https://doi.org/10.1158/1078-0432.CCR-09-0931
Published: 14 October 2009
View article
PDF
Includes: Supplementary data
Journal Articles

Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent

Anthony J. Mutsaers, Giulio Francia, Shan Man, Christina R. Lee, John M.L. Ebos, Yan Wu, Larry Witte, Scott Berry, Malcolm Moore, Robert S. Kerbel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2397–2405.
DOI: https://doi.org/10.1158/1078-0432.CCR-08-1627
Published: 01 April 2009
View article
PDF
Journal Articles

Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts

Jeanne M. du Manoir, Giulio Francia, Shan Man, Miriam Mossoba, Jeffrey A. Medin, Alicia Viloria-Petit, Daniel J. Hicklin, Urban Emmenegger, Robert S. Kerbel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 904–916.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-1109
Published: 07 February 2006
View article
PDF